Literature DB >> 18068945

Aloin induces apoptosis in Jurkat cells.

Eric J Buenz1.   

Abstract

Aloe is widely used as a dietary supplement. However, there are continuing concerns over the toxicity and the purity of aloe-based products. The primary class of compounds responsible for aloe-induced toxicity are anthraquinones. One of these, aloe-emodin, has been extensively investigated for apoptosis inducing effects. Conversely, the precursor to aloe-emodin, aloin, has been subjected to only minimal investigation of any cytotoxic effects. Jurkat T cells, an established model for the study of compound toxicity, were used to evaluate the effect of aloin on cell viability. Cells were analyzed using flow cytometry and microscopy for cell size and granularity, cell membrane integrity, mitochondrial membrane potential, and cell cycle profile. Treatment with aloin resulted in a reduction in cell size, compromised membrane integrity, and loss of mitochondrial membrane potential in a dose-dependent manner. Additionally, treatment with aloin resulted in alteration of the cell cycle, specifically a block at G2/M phase. Importantly, the loss of cell membrane integrity was preceded by a loss of mitochondrial membrane potential, suggesting a mitochondrial-dependent pathway for aloin-induced apoptosis. These observations provide insight into the potential mechanisms of aloin-induced toxicity and thus, perhaps, aloe preparation-induced toxicity. Furthermore, because of the concern over the safety of aloe-based supplements, this work suggests that aloe supplements not containing aloin may be safer than aloe supplements containing aloin, and that aloin should be considered in addition to concentrations of aloe-emodin.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18068945     DOI: 10.1016/j.tiv.2007.10.013

Source DB:  PubMed          Journal:  Toxicol In Vitro        ISSN: 0887-2333            Impact factor:   3.500


  7 in total

1.  Aloin promotes osteogenesis of bone-marrow-derived mesenchymal stem cells via the ERK1/2-dependent Runx2 signaling pathway.

Authors:  Peng Li; Junchao Kong; Zhuming Chen; Shuai Huang; Guihe Lv; Bo Wei; Jinsong Wei; Kaipeng Jing; Juanhua Quan; Jiaqi Chu
Journal:  J Nat Med       Date:  2018-09-14       Impact factor: 2.343

2.  Treatment-related changes after short-term exposure of SD rats to Aloe vera whole-leaf freeze-dried powder.

Authors:  Tao Chen; Li Wang; Chunyan Hu
Journal:  Int J Exp Pathol       Date:  2017-10       Impact factor: 1.925

3.  In vitro investigation of the mutagenic potential of Aloe vera extracts.

Authors:  Xiaoqing Guo; Suhui Zhang; Stacey L Dial; Mary D Boudreau; Qingsu Xia; Peter P Fu; Dan D Levy; Martha M Moore; Nan Mei
Journal:  Toxicol Res (Camb)       Date:  2014-08-11       Impact factor: 3.524

4.  Aloin suppresses lipopolysaccharide‑induced inflammation by inhibiting JAK1‑STAT1/3 activation and ROS production in RAW264.7 cells.

Authors:  Yunfei Ma; Tuo Tang; Lili Sheng; Ziqian Wang; Hong Tao; Qing Zhang; Yao Zhang; Zhilin Qi
Journal:  Int J Mol Med       Date:  2018-07-31       Impact factor: 4.101

Review 5.  Aloe Genus Plants: From Farm to Food Applications and Phytopharmacotherapy.

Authors:  Bahare Salehi; Sevil Albayrak; Hubert Antolak; Dorota Kręgiel; Ewelina Pawlikowska; Mehdi Sharifi-Rad; Yadav Uprety; Patrick Valere Tsouh Fokou; Zubaida Yousef; Zainul Amiruddin Zakaria; Elena Maria Varoni; Farukh Sharopov; Natália Martins; Marcello Iriti; Javad Sharifi-Rad
Journal:  Int J Mol Sci       Date:  2018-09-19       Impact factor: 5.923

6.  Aloin Inhibits the Proliferation and Migration of Gastric Cancer Cells by Regulating NOX2-ROS-Mediated Pro-Survival Signal Pathways.

Authors:  Ziqian Wang; Tuo Tang; Shengnan Wang; Tianyu Cai; Hong Tao; Qing Zhang; Shimei Qi; Zhilin Qi
Journal:  Drug Des Devel Ther       Date:  2020-01-14       Impact factor: 4.162

7.  Inhibition of the angiogenesis and growth of Aloin in human colorectal cancer in vitro and in vivo.

Authors:  Qin Pan; Hongming Pan; Haizhou Lou; Yinghua Xu; Lu Tian
Journal:  Cancer Cell Int       Date:  2013-07-12       Impact factor: 5.722

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.